SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MEDICAMEN BIOTECH

BSE: 531146 29 Sep 2025
Healthcare
₹ 343
Medicamen Biotech Ltd. specializes in Pharmaceuticals within the Healthcare sector.

MEDICAMEN BIOTECH - Share Price & Details

Market Cap
₹412.0
High /Low
630.0 / 298.0
Stock P/E
43.4
Book Value
₹168.0
Dividend Yield
0.33
ROCE
5.61
ROE
₹3.39
Face Value
10.0
PEG Ratio
-1.99
EVEBITDA
₹20.9
Debt
33.8
CMP / FCF
-34.2
Debt to equity
₹0.16
NP Ann
6.56
High price all time
1,225
Piotroski score
₹3.0
Graham Number
166.0
No. Eq. Shares
1.36
Net CF
₹-11.0
Net profit
7.28
Price to book value
1.81
Interest Coverage
₹3.9
Low price all time
4.75
Industry PE
33.0
Reserves
₹200
Free Cash Flow
₹-10.4

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
MEDICAMEN BIOTECH LTD.389.1916.37384.491.21412.043.4
MEDICO REMEDIES LIMITED389.118.18382.510.2240138.8
BROOKS LABORATORIES LTD.257.2926.51255.120.9399197.0

Peer Comparison Chart


About MEDICAMEN BIOTECH

Medicamen Biotech Ltd., with Security Code 531146, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Medicamen Biotech Stock Plummets to New 52-Week Low at Rs.320.25

(27 Sep 2025)
Medicamen Biotech has reached a new 52-week low, reflecting a significant decline in its stock price. The company has consistently...
Read more →

Medicamen Biotech Faces Continued Decline Amidst Challenging Financial Metrics

(19 Sep 2025)
Medicamen Biotech has reached a new 52-week low, continuing a downward trend with a significant annual decline in stock performance.
Read more →

Medicamen Biotech Hits 52-Week Low Amid Broader Market Gains and Underperformance

(18 Sep 2025)
Medicamen Biotech has reached a new 52-week low, underperforming in the Pharmaceuticals and Biotechnology sector despite a broader market rise.
Read more →

Medicamen Biotech Hits 52-Week Low Amid Broader Market Resilience

(17 Sep 2025)
Medicamen Biotech has reached a new 52-week low, underperforming its sector and experiencing a consecutive decline over the past two days.
Read more →

Bulls drive Nifty past 25,200; Sensex gains 595 points

(17 Sep 2025)
The overall market capitalisation of BSE-listed firms rose to nearly Rs 463 lakh crore from Rs 460 lakh crore in the previous session.
Read more →

55 stocks hit 52-week lows, 155 stocks at 52-week high as Nifty 50, Sensex end in green led by autos, banking

(16 Sep 2025)
Stock market today: On Tuesday, 155 stocks hit their 52-week highs, including Aadhar Housing Finance Ltd, Authum Investment & Infrastructure...
Read more →